Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neonicotinoid review delayed until autumn
bee
A recent study suggested exposure to neonicotinoids could impair bumblebees’ ability to learn, with negative consequences for ‘buzz pollination’.
Extra time needed to consider ‘large amount of information’

A review of three neonicotinoid pesticides, which are partially banned in the EU, has been delayed until later this year.

Restrictions were placed on the use of clothianidin, imidacloprid and thiametoxam in December 2013 owing to concerns about their impact on bees.

A review by the European Food Safety Authority (EFSA) was due to be finalised this month but will now be delayed until autumn 2017 “to ensure adequate time to consider the very large amount of information received during the call for data”.

An EFSA spokesperson said: “When it imposed controls on neonicotinoids in 2013 the European Commission announced that work on the full re-evaluation of the three neonicotinoids would begin within two years. In 2015, EFSA therefore issued a call for data and commissioned a literature search to gather evidence on which to base these new assessments.

“The information from the call for data included peer-reviewed articles published in journals, study reports, monitoring data, reviews, notes and datasets.”

EFSA is reviewing the risks to bees, looking at seed treatments and granules and taking new data into consideration. The food safety watchdog confirmed the three substances were a threat to bees when used as foliar sprays in 2015.

Much research has been published on the effects of neonicotinoids in recent years - last year alone imidacloprid and thiametoxam were found to reduce the lifespan and number of living sperm produced by male honey bees. Another 18-year study indicated a link between large scale bee declines and exposure to oilseed rape crops that had been treated with neonicotinoids.

A freedom of information request also revealed that studies commissioned by Bayer and Syngenta suggested their own pesticides could cause serious harm to honey bees at high concentrations.

Just last month, a study by the University of Stirling suggested exposure to neonicotinoids could impair bumblebees’ ability to learn, with negative consequences for a type of pollination, known as ‘buzz pollination’ that requires bees to produce vibrations.

Friends of the Earth is calling for a complete ban on the use of neonicotinoids, but National Farmers’ Union vice president Guy Smith is quoted by Farmers Weekly as saying a ban would be “unjustified” under current scientific evidence.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.